19.75
price up icon8.52%   1.55
after-market アフターアワーズ: 19.75
loading
前日終値:
$18.20
開ける:
$18.35
24時間の取引高:
3.34M
Relative Volume:
2.31
時価総額:
$974.98M
収益:
$230.59M
当期純損益:
$-96.37M
株価収益率:
-10.09
EPS:
-1.9571
ネットキャッシュフロー:
$-39.54M
1週間 パフォーマンス:
+21.91%
1か月 パフォーマンス:
+3.19%
6か月 パフォーマンス:
-29.08%
1年 パフォーマンス:
+21.76%
1日の値動き範囲:
Value
$18.20
$19.87
1週間の範囲:
Value
$16.32
$19.87
52週間の値動き範囲:
Value
$14.69
$30.81

Staar Surgical Co Stock (STAA) Company Profile

Name
名前
Staar Surgical Co
Name
セクター
Healthcare (1110)
Name
電話
(626) 303-7902
Name
住所
1911 WALKER AVE, MONROVIA, CA
Name
職員
1,211
Name
Twitter
@visianicl
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
STAA's Discussions on Twitter

Compare STAA vs ISRG, BDX, ALC, MDLN, RMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Instruments & Supplies icon
STAA
Staar Surgical Co
19.75 898.46M 230.59M -96.37M -39.54M -1.9571
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
494.02 174.76B 10.06B 2.88B 2.49B 7.876
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
182.49 52.44B 21.92B 1.76B 2.63B 6.1223
Medical Instruments & Supplies icon
ALC
Alcon Inc
84.13 40.70B 10.19B 1.05B 1.38B 2.1044
Medical Instruments & Supplies icon
MDLN
Medline Inc
49.99 40.28B 27.43B 1.27B 1.01B 1.5829
Medical Instruments & Supplies icon
RMD
Resmed Inc
251.63 37.99B 5.40B 1.49B 1.78B 10.12

Staar Surgical Co Stock (STAA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-02-03 開始されました Wedbush Neutral
2026-01-16 再開されました Morgan Stanley Underweight
2025-04-21 開始されました Wells Fargo Equal Weight
2025-02-12 ダウングレード BTIG Research Buy → Neutral
2025-02-12 ダウングレード Jefferies Buy → Hold
2025-02-12 ダウングレード Mizuho Outperform → Neutral
2025-02-12 ダウングレード William Blair Outperform → Mkt Perform
2024-07-15 ダウングレード Morgan Stanley Equal-Weight → Underweight
2024-06-11 アップグレード BTIG Research Neutral → Buy
2024-03-11 アップグレード Stifel Hold → Buy
2023-12-05 ダウングレード Needham Buy → Hold
2023-12-04 開始されました Morgan Stanley Equal-Weight
2023-09-15 ダウングレード The Benchmark Company Buy → Hold
2023-08-03 ダウングレード Canaccord Genuity Buy → Hold
2023-06-07 ダウングレード William Blair Outperform → Mkt Perform
2023-04-17 開始されました Piper Sandler Neutral
2023-02-06 ダウングレード BTIG Research Buy → Neutral
2022-12-28 繰り返されました BTIG Research Buy
2022-12-08 開始されました Stifel Hold
2022-11-07 アップグレード Sidoti Neutral → Buy
2022-10-14 再開されました Stephens Overweight
2022-10-13 開始されました Mizuho Buy
2022-04-08 開始されました Needham Buy
2022-03-28 アップグレード The Benchmark Company Hold → Buy
2022-03-18 アップグレード BTIG Research Neutral → Buy
2021-07-09 開始されました Oppenheimer Perform
2021-01-19 ダウングレード The Benchmark Company Buy → Hold
2020-10-26 ダウングレード Sidoti Buy → Neutral
2020-08-31 アップグレード Sidoti Neutral → Buy
2020-08-06 繰り返されました The Benchmark Company Buy
2020-07-06 ダウングレード Sidoti Buy → Neutral
2020-06-24 ダウングレード BTIG Research Buy → Neutral
2020-06-15 開始されました Jefferies Buy
2019-12-04 開始されました BTIG Research Buy
2018-09-24 繰り返されました The Benchmark Company Buy
2018-08-06 再開されました The Benchmark Company Buy
2017-11-20 繰り返されました The Benchmark Company Buy
2017-08-14 繰り返されました The Benchmark Company Buy
2017-03-03 繰り返されました The Benchmark Company Buy
2016-05-18 アップグレード The Benchmark Company Hold → Buy
2013-09-10 再開されました The Benchmark Company Buy
2013-02-28 繰り返されました The Benchmark Company Buy
2012-11-01 ダウングレード Canaccord Genuity Buy → Hold
2012-03-02 開始されました Northland Securities Outperform
2011-10-25 繰り返されました The Benchmark Company Buy
2010-10-12 開始されました Morgan Joseph Buy
2010-05-11 開始されました Benchmark Buy
すべてを表示

Staar Surgical Co (STAA) 最新ニュース

pulisher
Feb 23, 2026

Eye lens maker STAAR Surgical sets March 3 call on 2025 results, China recovery - Stock Titan

Feb 23, 2026
pulisher
Feb 20, 2026

FDA expands age indication for STAAR’s EVO ICL to patients aged 21–60 years - Optometry Times

Feb 20, 2026
pulisher
Feb 20, 2026

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Amidst a 27.10% Potential Upside - DirectorsTalk Interviews

Feb 20, 2026
pulisher
Feb 19, 2026

FDA approves expanded age indication for STAAR's EVO/EVO+ Visian ICLs - Eyes On Eyecare

Feb 19, 2026
pulisher
Feb 19, 2026

STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years - Yahoo Finance

Feb 19, 2026
pulisher
Feb 19, 2026

FDA Approves Expanded Age Range for STAAR Surgical’s EVO ICL for Vision Correction - VisionMonday.com

Feb 19, 2026
pulisher
Feb 18, 2026

Alcon launches TOTAL30 Multifocal for Astigmatism toric contact lens - Eyes On Eyecare

Feb 18, 2026
pulisher
Feb 18, 2026

Midday Stock Roundup: Staar Surgical up on FDA approval - Orange County Business Journal

Feb 18, 2026
pulisher
Feb 18, 2026

FDA expands age indication for Staar Surgical EVO ICL - MassDevice

Feb 18, 2026
pulisher
Feb 18, 2026

Why Is Staar Surgical Stock Gaining Wednesday?Staar Surgical (NASDAQ:STAA) - Benzinga

Feb 18, 2026
pulisher
Feb 17, 2026

Staar Surgical Gains Key FDA Approval to Broaden Patient Eligibility - AD HOC NEWS

Feb 17, 2026
pulisher
Feb 17, 2026

FDA approved expanded age indication for EVO/EVO+ Visian implantable lenses - TipRanks

Feb 17, 2026
pulisher
Feb 17, 2026

STAAR Surgical (STAA) Expands Lens Use with FDA Approval - GuruFocus

Feb 17, 2026
pulisher
Feb 17, 2026

FDA expands U.S. age indication for EVO ICL - marketscreener.com

Feb 17, 2026
pulisher
Feb 17, 2026

FDA clears STAAR eye lens for ages 21–60, opening option for 8M more - Stock Titan

Feb 17, 2026
pulisher
Feb 17, 2026

New Alcon lens helps aging eyes stay in contacts all month - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

Credit Industriel ET Commercial Invests $3.26 Million in STAAR Surgical Company $STAA - MarketBeat

Feb 16, 2026
pulisher
Feb 15, 2026

3 Low-Volatility Stocks We Find Risky - Finviz

Feb 15, 2026
pulisher
Feb 13, 2026

New York Life Investment Management LLC Takes Position in STAAR Surgical Company $STAA - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

STAAR Surgical Company (STAA) Stock Analysis: Exploring a 37.81% Potential Upside for Investors - DirectorsTalk Interviews

Feb 13, 2026
pulisher
Feb 12, 2026

Alpine Associates Management Inc. Acquires Shares of 913,087 STAAR Surgical Company $STAA - MarketBeat

Feb 12, 2026
pulisher
Feb 11, 2026

VIEW Optometry launches to support independent practices - Eyes On Eyecare

Feb 11, 2026
pulisher
Feb 10, 2026

STAAR Surgical Company (NASDAQ:STAA) Given Average Recommendation of "Reduce" by Analysts - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

212,421 Shares in STAAR Surgical Company $STAA Acquired by Versor Investments LP - MarketBeat

Feb 10, 2026
pulisher
Feb 09, 2026

Eli Lilly To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Feb 09, 2026
pulisher
Feb 09, 2026

STAAR Surgical (NASDAQ:STAA) Given New $19.00 Price Target at Stifel Nicolaus - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Staar Surgical price target lowered to $19 from $28 at Stifel - TipRanks

Feb 09, 2026
pulisher
Feb 09, 2026

Leadership watch: Staar Surgical names co-CEOs, ACET adds to Board - Eyes On Eyecare

Feb 09, 2026
pulisher
Feb 09, 2026

STAAR Surgical stock price target lowered to $19 by Stifel on China concerns By Investing.com - Investing.com India

Feb 09, 2026
pulisher
Feb 09, 2026

STAAR Surgical stock price target lowered to $19 by Stifel on China concerns - Investing.com Nigeria

Feb 09, 2026
pulisher
Feb 05, 2026

Staar Surgical CoEnters agreement with Chief Legal Officer Nathaniel SisitskySEC filing - marketscreener.com

Feb 05, 2026
pulisher
Feb 04, 2026

STAAR Surgical Company (STAA): A Bull Case Theory - Finviz

Feb 04, 2026
pulisher
Feb 04, 2026

Staar Surgical initiated with a Neutral at Wedbush - TipRanks

Feb 04, 2026
pulisher
Feb 03, 2026

STAAR Surgical sinks as it plans to terminate sale to Alcon (update) - MSN

Feb 03, 2026
pulisher
Feb 03, 2026

Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth - Finviz

Feb 03, 2026
pulisher
Feb 03, 2026

STAA Receives Neutral Rating as Wedbush Initiates Coverage | STA - GuruFocus

Feb 03, 2026
pulisher
Feb 03, 2026

STAAR names interim co-CEOs amid search for permanent leader - MedTech Dive

Feb 03, 2026
pulisher
Feb 03, 2026

STAAR Surgical (NASDAQ:STAA) Now Covered by Wedbush - MarketBeat

Feb 03, 2026
pulisher
Feb 03, 2026

STAAR Surgical (STAA) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Feb 03, 2026
pulisher
Feb 03, 2026

STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOs - VisionMonday.com

Feb 03, 2026
pulisher
Feb 02, 2026

Why STAAR Surgical (STAA) stock is trading lower today - MSN

Feb 02, 2026
pulisher
Feb 02, 2026

Staar Surgical names interim co-CEOs in leadership shift following failed Alcon deal - massdevice.com

Feb 02, 2026
pulisher
Feb 02, 2026

Why STAAR Surgical (STAA) Shares Are Down Today - Bitget

Feb 02, 2026
pulisher
Feb 02, 2026

Why STAAR Surgical (STAA) Stock Is Trading Lower Today - Finviz

Feb 02, 2026
pulisher
Feb 02, 2026

Staar Surgical Appoints Interim Co-CEOs - Orange County Business Journal

Feb 02, 2026
pulisher
Feb 02, 2026

STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs - PharmiWeb.com

Feb 02, 2026
pulisher
Feb 02, 2026

New weekly contact lens offers Canadians 16 hours of daily comfort - stocktitan.net

Feb 02, 2026
pulisher
Feb 02, 2026

Staar Surgical appoints Warren Foust & Deborah Andrews interim co-CEOs - marketscreener.com

Feb 02, 2026
pulisher
Feb 02, 2026

STAAR Surgical Company Announces Interim Co-CEO Appointments, Effective February 1, 2026 - marketscreener.com

Feb 02, 2026
pulisher
Feb 02, 2026

Staar Surgical (STAA) Appoints Interim Co-CEOs as CEO Search Beg - GuruFocus

Feb 02, 2026
pulisher
Feb 02, 2026

A month after Alcon deal fell through, Staar Surgical searches for next CEO and names interim leaders - Fierce Biotech

Feb 02, 2026

Staar Surgical Co (STAA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$73.42
price up icon 1.06%
$185.53
price up icon 2.36%
medical_instruments_supplies COO
$83.56
price up icon 0.75%
$75.35
price down icon 0.12%
medical_instruments_supplies WST
$245.38
price up icon 0.47%
medical_instruments_supplies RMD
$251.63
price down icon 3.51%
大文字化:     |  ボリューム (24 時間):